Bicyclic heterocycles as HIV integrase inhibitors
US7176196B2 · kind B2 · utility
15Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2005 |
| Grant date | Feb 13, 2007 |
| Priority date | — |
| Expiry date | May 13, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.